CylvexCYLVEX·
$LIVN filed an 8-K with results (Item 2.02) at 6:01 AM ET on Wed, Nov 4.
+9.60 (+12.02%) TodayNov 4, 9:32 AM ET
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Q3 revenue $393.1M (+9.9% YoY), EPS $0.11 GAAP, adjusted EPS $1.23; FY guidance revenue growth 9-10%, adjusted EPS $4.40–4.50 · per SEC filing
Sources: SEC filing
AI generated · From SEC filing · Not investment advice
Q3 revenue $393.1M (+9.9% YoY), EPS $0.11 GAAP, adjusted EPS $1.23; FY guidance revenue growth 9-10%, adjusted EPS $4.40–4.50 · per SEC filing
From the company’s SEC filing: its figures, summarized by AI.
Sources: SEC filing
Written 7:30 AM ET · last check 9:00 AM ET
AI generated · May contain errorsFrom SEC filing · Not investment adviceSign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about LIVN?
CylvexCYLVEX·
$LIVN filed an 8-K with results (Item 2.02) at 6:01 AM ET on Wed, Nov 4.
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›